News

The cryptocurrency industry is engaged in a heated battle with the Securities and Exchange Commission (SEC), challenging the agency's aggressive enforcement tactics and demanding greater accountability. This pushback comes as the industry finds itself on more favorable ground under the Trump administration, with Republicans in Congress working to establish clearer jurisdictional boundaries for the SEC.

Arcutis Biotherapeutics' Zoryve cream, a steroid-free treatment for mild to moderate atopic dermatitis, has been approved by Health Canada, offering Canadians a new option for managing the condition and its associated symptoms. The cream demonstrated significant improvements in clinical trials, with 90% of patients experiencing symptom improvement within four weeks and 69% achieving at least a 50% reduction in disease severity.

Robinhood Markets, Inc. (HOOD) launched a new prediction markets hub, allowing users to trade on the outcome of real-world events like the target federal funds rate and the College Basketball Tournaments. HOOD shares rose 9.25% following the announcement, reflecting investor enthusiasm for this innovative platform.

Butterfly Network, a digital health company providing portable ultrasound technology, exceeded expectations with a 35% year-over-year sales increase in the fourth quarter. Analysts are optimistic about the company's future growth potential, particularly in the homecare market, and believe the current share price undervalues its potential.

Peter Schiff, a prominent Bitcoin critic, highlighted the surge in gold prices and the decline in Bitcoin's value, arguing that market momentum is swinging back toward gold. He believes that Bitcoin's potential collapse could lead to mass sell-offs and raise doubts about its status as a store of value.